DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,833,004 | +6.2% | 15,449 | +2.7% | 0.43% | +18.7% |
| Q2 2023 | $3,609,928 | -8.8% | 15,041 | -4.3% | 0.36% | -16.4% |
| Q1 2023 | $3,960,126 | -11.3% | 15,712 | -6.6% | 0.43% | -20.7% |
| Q4 2022 | $4,465,222 | +1.4% | 16,823 | -1.3% | 0.55% | -4.9% |
| Q3 2022 | $4,403,000 | +2.7% | 17,046 | +0.8% | 0.58% | +8.7% |
| Q2 2022 | $4,287,000 | -2.0% | 16,908 | +13.3% | 0.53% | -1.5% |
| Q1 2022 | $4,376,000 | -9.3% | 14,918 | +1.7% | 0.54% | -7.3% |
| Q4 2021 | $4,825,000 | -2.1% | 14,666 | -9.4% | 0.58% | -10.2% |
| Q3 2021 | $4,926,000 | +11.9% | 16,180 | -1.4% | 0.64% | +8.2% |
| Q2 2021 | $4,404,000 | +19.0% | 16,412 | -0.2% | 0.60% | +6.6% |
| Q1 2021 | $3,700,000 | -0.2% | 16,437 | -1.6% | 0.56% | -5.3% |
| Q4 2020 | $3,709,000 | +4.4% | 16,697 | +1.2% | 0.59% | -9.0% |
| Q3 2020 | $3,552,000 | +14.9% | 16,497 | -5.7% | 0.65% | +3.5% |
| Q2 2020 | $3,092,000 | +26.6% | 17,488 | -0.9% | 0.63% | +7.6% |
| Q1 2020 | $2,443,000 | -19.3% | 17,653 | -10.5% | 0.58% | -4.1% |
| Q4 2019 | $3,026,000 | +22.5% | 19,717 | +15.3% | 0.61% | +1.0% |
| Q3 2019 | $2,470,000 | -10.8% | 17,101 | -11.8% | 0.60% | -8.7% |
| Q2 2019 | $2,770,000 | +24.8% | 19,380 | +15.2% | 0.66% | +5.8% |
| Q1 2019 | $2,220,000 | +30.5% | 16,819 | +2.0% | 0.62% | +21.7% |
| Q4 2018 | $1,701,000 | -10.0% | 16,496 | -5.2% | 0.51% | +7.4% |
| Q3 2018 | $1,890,000 | +64.9% | 17,396 | +49.8% | 0.48% | +24.6% |
| Q2 2018 | $1,146,000 | +10.9% | 11,611 | +10.1% | 0.38% | +10.1% |
| Q1 2018 | $1,033,000 | -9.9% | 10,546 | -14.7% | 0.35% | -4.7% |
| Q4 2017 | $1,147,000 | +7.9% | 12,361 | -0.3% | 0.36% | +5.5% |
| Q3 2017 | $1,063,000 | +262.8% | 12,396 | +256.6% | 0.34% | +248.5% |
| Q2 2017 | $293,000 | -1.3% | 3,476 | 0.0% | 0.10% | -4.8% |
| Q1 2017 | $297,000 | +9.6% | 3,476 | 0.0% | 0.10% | +7.2% |
| Q4 2016 | $271,000 | -0.4% | 3,476 | 0.0% | 0.10% | -1.0% |
| Q3 2016 | $272,000 | -99.9% | 3,476 | -20.6% | 0.10% | -40.2% |
| Q1 2016 | $415,107,000 | +112395.1% | 4,376 | +10.1% | 0.16% | +5.1% |
| Q4 2015 | $369,000 | – | 3,976 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |